GSK to produce 1bn doses of coronavirus vaccine booster in 2021
by Reuters from Science | The Guardian on (#540RQ)
World's largest vaccine maker in talks with governments over manufacturing expansion
GlaxoSmithKline plans to produce 1bn doses of vaccine efficacy boosters, or adjuvants, next year for use in Covid-19 treatment.
The world's largest vaccine maker said it was in talks with governments to back a manufacturing expansion that would help to scale up production of future vaccines for Covid-19.
Continue reading...